The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone-Reference-Cited by-同舟云学术

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

Published:2008-01 Issue:6 Volume:13 Page:618-636
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Akuffo Emma L.,Davis John B.,Fox Steven M.,Gloger Israel S.,Hosford David,Kinsey Emma E.,Jones Neil A.,Nock Christina M.,Roses Allen D.,Saunders Ann M.,Mark Skehel J.,Smith Marjorie A.,Cutler Paul

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

http://www.tandfonline.com/doi/pdf/10.1080/13547500802445199

Reference20 articles.

1. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale

2. Role of complement in neurodegeneration and neuroinflammation

3. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma

4. C1 inhibitor: Biologic activities that are independent of protease inhibition

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of an APOE ε4–specific blood‐based molecular pathway for Alzheimer's disease risk;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-10

2. Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders;Frontiers in Immunology;2023-01-20

3. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study;Alzheimer's Research & Therapy;2023-01-12

4. Microglial Immunoregulation by Apoptotic Cellular Membrane Mimetic Polymeric Particles;ACS Macro Letters;2022-01-28

5. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics;ACS Chemical Neuroscience;2021-06-14